|
|
News Breaks
|
November 9, 2009
|
| 07:12 EDT |  | AMRI |
| theflyonthewall.com: | Albany Molecular sees FY09 EPS (1c)-(5c) vs. consensus of 13c | | AMRI CFO Mark T. Frost said: "EPS includes the impact of the $1.9M, or 4c per basic and diluted share, of non-cash inventory write-downs primarily related to a legacy generic API recorded in the Q2. The revised full year guidance includes a lower tax benefit due to the mix of domestic and international pre-tax income/loss as well as a catch-up for 2008 income taxes. Forecasted operating results for the full year 2009 have not significantly changed from our previous guidance". :theflyonthewall.com |
|
|
News For AMRI From The Last 14 Days Check below for free stories on AMRI the last two weeks.
There are 6 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
|
|
|